Полимерные системы с контролируемым высвобождением биологически активных соединений
Published in Biotechnologia Acta • Jan 1, 2011
Authors:
М. В. Григорьева
Abstract
Because of the small number of patients randomized, we were unable to determine whether ABMT or a standard salvage regimen (DHAP) is superior for PR patients. However, we confirmed that myeloablative treatment is a safe and well-tolerated procedure in this category of patients and this may enable us...
Subject
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!